Navigation Links
Edwards Lifesciences Celebrates One Million Heart Valve Patients and More at AATS 2008
Date:5/8/2008

the exhibition area at booth #1001. The booth features information on the new products and simulators for hands-on experience in transcatheter and minimally-invasive surgery techniques.

Clinical Presentations

Among the clinical presentations featuring data about Edwards' devices are:
Sunday, May 11

-- Session V, Percutaneous Aortic Valve Replacement: Update on

Percutaneous AVR with Edwards SAPIEN Valve (retrograde and antegrade)

-- 4:15 p.m. to 4:35 p.m. Ballroom 20 A-C, San Diego Convention

Center. Presenter: John G. Webb, St. Paul's Hospital, Vancouver, BC,

Canada.

-- Session V, Percutaneous Aortic Valve Replacement: Identification of

Appropriate Patients: Who Actually is "Inoperable"? -- 4:55 p.m. to

5:15 p.m. Ballroom 20 A-C, San Diego Convention Center. Presenter:

Michael J. Mack, Cardiothoracic Surgery Associates of North Texas,

Dallas, TX.

Wednesday, May 14

-- Emerging Technologies and Techniques Forum: Is Transcatheter Based

Aortic Valve Implantation Really Less Invasive than Minimal Invasive

Aortic Valve Replacement? -- 7:13 a.m. to 7:26 a.m. Room 25, San Diego

Convention Center. Presenters/authors: Mirko Doss, Sven Martens,

Stephan Fichtelscherer, Thomas Trepels, Gerhard Wimmer Greinecker,

Anton Moritz, Volker Schachinger, Thoracic and Cardiovascular Surgery,

J.W. Goethe University Frankfurt, Frankfurt am Main, Germany.

-- Emerging Technologies and Techniques Forum: Transapical Transcatheter

Aortic Valve Implantation One Year Follow-Up in 19 Patients --

8:05 a.m. to 8:18 a.m. Room 25, San Diego Convention Center.

Presenters/authors: Jian Ye, Anson Cheung, John G. Webb, Daniel R.

Wong, Ronald G. Carere, Christopher R. Thompson, Samuel V.

Lichtenstein, Cardiothoracic Surgery, University of British Columbia,

Vancouver
'/>"/>

SOURCE Edwards Lifesciences Corporation
Copyright©2008 PR Newswire.
All rights reserved

Page: 1 2 3 4

Related biology technology :

1. Favrille to Present at AG Edwards Emerging Growth Conference and Wall Street Analyst Forum
2. Bionovo to Present at A.G. Edwards 2nd Annual Emerging Growth Conference 2007
3. Edwards Lifesciences Grants UC Irvine $5 Million to Establish the Edwards Lifesciences Center for Advanced Cardiovascular Technology
4. Medarex to Present at the A.G. Edwards 2nd Annual Emerging Growth Conference
5. Marshall Edwards, Inc. to Present at BIO Investor Forum 2007
6. Edwards Lifesciences Forecasts Strong Growth in 2008
7. Edwards Lifesciences Completes Acquisition of CardioVations Product Line
8. Edwards Lifesciences Receives FDA Approval to Add Transapical Delivery System to U.S. Clinical Trial of Transcatheter Heart Valve
9. Edwards Lifesciences to Host Earnings Conference Call on February 5, 2008
10. Edwards Lifesciences to Present at the Merrill Lynch Global Pharmaceutical, Biotechnology & Medical Device Conference
11. Edwards Lifesciences Announces Organizational Changes
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:1/22/2015)... (PRWEB) January 22, 2015 The laboratory ... that has witnessed a number of technological advancements due ... regulatory requirements, growing need to integrate healthcare systems, and ... ease challenges in system integration. Key players in the ...
(Date:1/22/2015)... January 22, 2015 Dr. Greg Leyer of ... annual Scripps Natural Supplements Pre-Conference seminar on probiotics in San ... an annual continuing education conference for health care professionals. This ... the topic of probiotics in health. Dr. Leyer spoke about ...
(Date:1/22/2015)... Jan. 22, 2015   Cypher Genomics, Inc., ... (NASDAQ: SQNM ), the leading molecular ... next generation noninvasive prenatal tests (NIPT). Through this ... called Mantis™, to advance analysis of clinically-relevant fetal ...
(Date:12/24/2014)... , Dec. 24, 2014  United Therapeutics Corporation (NASDAQ: ... MDT ) has submitted a pre-market approval ... for the use of Medtronic,s SynchroMed ® II ... for use with United Therapeutics, Remodulin ® (treprostinil) ...
Breaking Biology Technology:Laboratory Information Management Systems Market is Expected to Reach $1,323.6 Million by 2019 - New Research Report by MarketsandMarkets 2Laboratory Information Management Systems Market is Expected to Reach $1,323.6 Million by 2019 - New Research Report by MarketsandMarkets 3Laboratory Information Management Systems Market is Expected to Reach $1,323.6 Million by 2019 - New Research Report by MarketsandMarkets 4Cypher Genomics and Sequenom Announce Development Agreement 2Cypher Genomics and Sequenom Announce Development Agreement 3Cypher Genomics and Sequenom Announce Development Agreement 4United Therapeutics Announces Submission Of Pre-Market Approval Application For Implantable Drug Infusion System To Deliver Remodulin 2United Therapeutics Announces Submission Of Pre-Market Approval Application For Implantable Drug Infusion System To Deliver Remodulin 3United Therapeutics Announces Submission Of Pre-Market Approval Application For Implantable Drug Infusion System To Deliver Remodulin 4
... Technology to Find a Faster, More Accurate ... 1 ChemImage, ( www.chemimage.com ) today ... Breath, LLC ( www.nextbreath.net ), a leading ... ChemImage,s Raman Chemical Imaging for bioequivalence applications ...
... PETACH TIKVA, Israel, April 1 NexGen Biofuels,Ltd. ... a non-binding,Letter of Intent with World Venture Management ... ("WVM" ) and Mac Bioventures, Inc. The transaction,includes ... relating to its Real,Estate acquisitions and asset management ...
... 1 /PRNewswire-FirstCall/ - SemBioSys Genetics Inc. (TSX:SBS), ... and oils in plant seeds, provides an ... insulin program. In December 2008, SemBioSys announced ... to license rights to SemBioSys, proprietary plant-produced ...
Cached Biology Technology:ChemImage and Next Breath Structure Partnership to Validate Bioequivalence Testing for Nasal Spray Suspensions 2ChemImage and Next Breath Structure Partnership to Validate Bioequivalence Testing for Nasal Spray Suspensions 3NexGen Biofuels Ltd Signs Letter of Intent for the Purchase of World Venture Management, Inc. Assets and the Sale of its Current Business 2SemBioSys provides update on insulin program 2SemBioSys provides update on insulin program 3
(Date:1/22/2015)... CHARLOTTE, N.C. , Jan. 22, 2015 Infinisource has ... introduction of the G2 model. The G2 sets a higher ... company,s iSolved human capital management solution. With plug-and-play installation, touch ... G2 time clock provides a robust time collection solution for ...
(Date:12/22/2014)... Dec. 22, 2014  The 2014 Holiday Season may be ... Market Intelligence reports that the long anticipated floodgates for ... intensifying demand for smart phones, tablets, and wearable mobile ... of 2.5 billion users with nearly 4.8 billion biometric ...
(Date:12/19/2014)... LAS VEGAS , Dec. 18, 2014   LaunchKey ... built for the post-password and Internet of Things era, ... seed funding. The venture round was led by Metamorphic ... Capital, Rimrock Venture Partners, VegasTechFund, and others.  LaunchKey has ...
Breaking Biology News(10 mins):Infinisource's NXG series sets new time clock standard 2First Season of Holiday Shopping with Mobile Biometric Payments Wraps Up With a Present for Biometrics Industry: A Rosy Forecast for More Than 2 Billion Users of 4.8 Billion Mobile Biometric Devices by 2020 2LaunchKey Raises $3 Million in Additional Funding Led by Metamorphic Ventures 2LaunchKey Raises $3 Million in Additional Funding Led by Metamorphic Ventures 3
... Mass. CellThera, a biotechnology company located in ... at Gateway Park, has received a contract from ... to extend its research program in tissue regeneration. ... is part of WPI,s Bioengineering Institute (BEI), and ...
... the Helmholtz scientists and their clinical partners want to ... disease and gain perspectives for early diagnosis and therapy. ... online in the journal Nature Genetics . ... (QT Interval and Sudden Cardiac Death), Dr. Arne Pfeufer ...
... are used to thinking of heart disease as a product ... eat and how much we exercise. There is another road ... increase in particulate air pollution is associated with an increase ... relatively new field of environmental cardiology -- a field that ...
Cached Biology News:CellThera and WPI advance in regeneration study 2Genetic risk factors identified for sudden cardiac death 2Genetic risk factors identified for sudden cardiac death 3Inhaling a heart attack: How air pollution can cause heart disease 2Inhaling a heart attack: How air pollution can cause heart disease 3
Rabbit polyclonal to Survivin DEx3 ( Abpromise for all tested applications). entrezGeneID: 332 SwissProtID: O15392...
Anti-Mouse C-10, Biotin (Polyclonal) (rabbit IgG)...
Goat polyclonal to SART3 ( Abpromise for all tested applications). Antigen: Synthetic peptide: MSNADFAKLFLRK, corresponding to C terminal amino acids 951-963 of Human SART3 Entrez Gene ID: 9...
... The FastPlax Antibody is used to ... on the surface of infected cells as ... the basis of the FastPlax Titer Kit, ... just 25-48 hours. The FastPlax ...
Biology Products: